BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30370442)

  • 1. Growth hormone-secreting pituitary macroadenoma presenting concurrently with non-Hodgkin's lymphoma and responding to doxorubicin treatment: case report and review of the literature.
    Lekovic GP; Batra A; Barnard ZR; Wilkinson EP; Balena R; Palejwala S; Barkhoudarian G
    Acta Neurochir (Wien); 2018 Dec; 160(12):2363-2366. PubMed ID: 30370442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of R-CHOP/CHOP therapy-induced nausea and vomiting in non-Hodgkin's lymphoma patients: a comparison of intravenous and oral 5-HT3 receptor antagonists.
    Takahashi T; Kumanomidou S; Takami S; Okada T; Adachi K; Jo Y; Ikejiri F; Onishi C; Kawakami K; Miyake T; Inoue M; Moriyama I; Suzuki R; Suzumiya J
    Int J Hematol; 2016 Sep; 104(3):378-83. PubMed ID: 27312042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary endometrial non-Hodgkin's lymphoma treated by chemotherapy and radiotherapy.
    Guldrís EM; Vázquez P; Fernández A
    Acta Obstet Gynecol Scand; 2013 May; 92(5):606. PubMed ID: 23398244
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates.
    Peters FP; Fickers MM; Erdkamp FL; Wals J; Wils JA; Schouten HC
    Ann Hematol; 2001 Jul; 80(7):406-10. PubMed ID: 11529466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective immunochemotherapy for aggressive non-Hodgkin's lymphoma.
    Coiffier B
    Semin Oncol; 2004 Feb; 31(1 Suppl 2):7-11. PubMed ID: 15042528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocal primary bone lymphoma: durable complete remission after R-CHOP chemotherapy.
    Mohamed M; Brain T; Sharma S
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23704456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary non-Hodgkin's lymphoma of liver with humoral hypercalcaemia.
    Santhosh-Kumar CR; Ajarim DS; Shipkey FD
    Postgrad Med J; 1990 Aug; 66(778):679-81. PubMed ID: 1699217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
    Reilly TB; Schuster DM; Starsiak MD; Kost CB; Halkar RK
    Clin Nucl Med; 2007 Jul; 32(7):569-71. PubMed ID: 17581351
    [No Abstract]   [Full Text] [Related]  

  • 9. Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.
    Herrmann K; Wieder HA; Buck AK; Schöffel M; Krause BJ; Fend F; Schuster T; Meyer zum Büschenfelde C; Wester HJ; Duyster J; Peschel C; Schwaiger M; Dechow T
    Clin Cancer Res; 2007 Jun; 13(12):3552-8. PubMed ID: 17575218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
    Alliot C
    J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of primary rectal non-Hodgkin's lymphoma treated with chemotherapy.
    Singla R; Kumar P; Bahl A; Kumar S; Saran RK; Kar P
    Trop Gastroenterol; 2008; 29(4):227-8. PubMed ID: 19323094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective comparison between CHOP-PVP and CHOP protocols for non-Hodgkin's lymphoma.
    Gan H; Zhang F; Lin Y
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):397-9. PubMed ID: 12408775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of R-CHOP chemotherapy on liver and mediastinal blood pool (18)F-FDG standardized uptake values in patients with non-Hodgkin's lymphoma.
    Kaya B; Dostbil Z; Ismailoglu M; Tasdemir B; Sahin O
    Clin Imaging; 2015; 39(4):632-5. PubMed ID: 25709112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHOP versus m-BACOD in non-Hodgkin's lymphoma.
    Hryniuk W
    N Engl J Med; 1993 Feb; 328(8):581. PubMed ID: 7678920
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II study.
    Späth-Schwalbe E; Lange C; Genvresse I; Krüger L; Eucker J; Schweigert M; Sezer O; Budach V; Possinger K
    Anticancer Drugs; 2002 Apr; 13(4):395-403. PubMed ID: 11984085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Hodgkin's lymphoma presenting as thyroid and adrenal gland involvement.
    Erdoğan G; Güllü S; Colak T; Kamel AN; Başkal N; Ekinci C
    Endocr J; 1997 Feb; 44(1):199-203. PubMed ID: 9152635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute upper arm ischaemia: a rare presentation of non-Hodgkin's lymphoma.
    Daruwalla ZJ; Razak AR; Duke D; Grogan L
    Ir J Med Sci; 2010 Dec; 179(4):589-92. PubMed ID: 18696175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary ovarian lymphoma--a rare entity.
    Afshan A; Sadaf N
    J Pak Med Assoc; 2013 Apr; 63(4):519-20. PubMed ID: 23905454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis on Rituximab combined CHOP chemotherapy for non-Hodgkin lymphoma in China.
    Hou S; Yang W
    Saudi Med J; 2011 Jul; 32(7):675-8. PubMed ID: 21748202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral lower extremity swelling as a rare presentation of non-Hodgkin's lymphoma.
    Elgendy IY; Lo MC
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24431414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.